Mark. A Glickman
Overview
Mark. A Glickman received an average of $5M in total compensation, including $381K in salary, at Esperion Therapeutics between 2018 and 2019.
Source: SEC filings on April 16, 2020 and April 18, 2019.
Related executives
We found 11 more executives who work or worked at Esperion Therapeutics.
Sheldon Koenig
Esperion Therapeutics
Chief Executive Officer
JoAnne Foody
Esperion Therapeutics
Chief Medical Officer
Eric Warren
Esperion Therapeutics
Chief Commercial Officer
Benjamin Looker
Esperion Therapeutics
General Counsel
Tim Mayleben
Esperion Therapeutics
Chief Executive Officer
Richard Bartram
Esperion Therapeutics
Chief Financial Officer
Ashley Hall
Esperion Therapeutics
Former Chief Development Officer
Narendra DABT
Esperion Therapeutics